Provided by Tiger Fintech (Singapore) Pte. Ltd.

Crinetics Pharmaceuticals Inc.

33.31
+0.20000.60%
Pre-market: 33.310.00000.00%08:02 EDT
Volume:737.02K
Turnover:24.52M
Market Cap:3.10B
PE:-9.02
High:33.59
Open:32.98
Low:32.21
Close:33.11
Loading ...

Crinetics Pharmaceuticals Q4 Net Loss Narrows

MT Newswires Live
·
28 Feb

Earnings Flash (CRNS) Crinetics Pharmaceuticals Q4 Loss Per Share $0.88 vs. FactSet Est Loss $0.89

MT Newswires Live
·
28 Feb

Crinetics Pharmaceuticals Q4 GAAP EPS $(0.88), Inline

Benzinga
·
28 Feb

BRIEF-Crinetics Pharmaceuticals Q4 Net Income USD -80.595 Million

Reuters
·
28 Feb

Crinetics Pharmaceuticals Inc: for 2025, We Anticipate Our Cash Used in Operations to Be Between $340 and $380 Mln

THOMSON REUTERS
·
28 Feb

Is Crinetics Pharmaceuticals (CRNX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
28 Feb

Investors push Crinetics Pharmaceuticals (NASDAQ:CRNX) 11% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
27 Feb

Crinetics Pharmaceuticals Names Tobin Schilke CFO

MT Newswires Live
·
24 Feb

Crinetics Pharmaceuticals Hires CFO from Revance

Dow Jones
·
24 Feb

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

THOMSON REUTERS
·
24 Feb

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

GlobeNewswire
·
24 Feb

BUZZ-Crinetics gains after TD Cowen starts with 'buy' on optimism for lead drugs

Reuters
·
11 Feb

TD Cowen Initiates Crinetics Pharmaceuticals at Buy

MT Newswires Live
·
11 Feb

Crinetics Pharmaceuticals Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
11 Feb

Crinetics initiated with a Buy at TD Cowen

TIPRANKS
·
11 Feb

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Feb

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

GlobeNewswire
·
07 Feb

Crinetics Pharmaceuticals, Inc. (CRNX): One of January’s Biggest Losers

Insider Monkey
·
06 Feb

Crinetics Pharmaceuticals Initiated at Peer Perform by Wolfe Research

Dow Jones
·
05 Feb

Wolfe Research Initiates Coverage on Crinetics Pharmaceuticals With Peer Perform Rating

MT Newswires Live
·
04 Feb